Marker Therapeutics, Inc. (MRKR)

1.48 +0.03 (+2.07%) USD  |  NASDAQ  |  Feb 23, 11:42
More

Marker Therapeutics Hold Recommendations

Hold Recommendations Chart

View Hold Recommendations for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Hold Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Hold Recommendations Range, Past 5 Years

View Hold Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Hold Recommendations Benchmarks

View Hold Recommendations Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. Upgrade